AIFF Firefly Neuroscience, Inc. - Fundamental Analysis

AIFF exhibits severe financial distress, as evidenced by a Piotroski F-Score of 1/9 (indicating extreme financial weakness) and a lack of an Altman Z-Score, which raises significant bankruptcy risk. Despite a remarkable 1075.8% YoY revenue growth, the company operates at a massive loss, with a negative operating margin of -632.47% and ROE of -340.82%, signaling unsustainable operations. The stock trades at a steep Price/Sales of 13.39 and has declined over 98% in the past five years, reflecting deep investor skepticism. Insider selling totaling $1.02M in the last six months further undermines confidence, while the absence of analyst coverage and dividend yield confirms a speculative, high-risk profile.